Symbol: |
EVC
|
Description: |
Ellis van Creveld syndrome [Source:HGNC Symbol;Acc:3497]
|
Location: |
Chr4:5712924-5830772[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:163
Gene |
Compound |
Gen_sig |
Exp_pattern |
EVC |
2-Naphthacenecarboxamide, N-[(6,7-dihydro-7-oxo-v-triazolo[4,5-d]pyrimidin-5-ylamino)methyl]-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo- |
0.022 |
Up |
EVC |
11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- |
0.044 |
Up |
EVC |
NSC 676819 |
0.047 |
Up |
EVC |
Isokanugin |
0.01 |
Down |
EVC |
NSC 679509 |
0.001 |
Down |
EVC |
NSC 680417 |
0.048 |
Down |
EVC |
NSC 680551 |
0.049 |
Down |
EVC |
2-Quinoxalinecarboxylic acid, 3-[(4-fluorophenyl)amino]-, ethyl ester |
0.009 |
Down |
EVC |
N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4-chloro-2-mercapto-5-methylbenzenesulfonamide |
0.013 |
Up |
EVC |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,leucine deriv. |
0.027 |
Down |
EVC |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,isoleucine deriv. |
0.012 |
Down |
EVC |
NSC 681749 |
0.04 |
Down |
EVC |
NSC 683140 |
0.008 |
Down |
EVC |
NSC 684981 |
0.015 |
Down |
EVC |
NSC 684987 |
0.049 |
Down |
Expression pattern: Sensitivity / Resistance
Total:11 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:118
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:4
Gene |
Gen_transcript |
miRNA |
miR_location |
EVC |
ENST00000264956 |
hsa-mir-425-5p |
Chr3:49057632-49057654[-] |
EVC |
ENST00000382674 |
hsa-mir-425-5p |
Chr3:49057632-49057654[-] |
EVC |
ENST00000382674 |
hsa-mir-541-5p |
Chr14:101530841-101530865[+] |
EVC |
ENST00000382674 |
hsa-mir-614 |
Chr12:13068816-13068838[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|